Shopping Cart
Remove All
Your shopping cart is currently empty
Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) inhibitor, exhibiting an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,670 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $2,180 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,800 | 6-8 weeks | 6-8 weeks |
| Description | Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) inhibitor, exhibiting an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM. |
| Targets&IC50 | MCL1:0.03 nM (ki) |
| In vitro | Mcl1-IN-9 effectively inhibits the proliferation of Mcl-1 dependent tumor cell lines at nanomolar concentrations. |
| In vivo | Mcl1-IN-9 inhibits the growth of triple-negative breast cancer xenografts and hematological malignancies at well-tolerated doses. |
| Molecular Weight | 639.18 |
| Formula | C37H39ClN4O4 |
| Cas No. | 1810769-31-3 |
| Relative Density. | 1.28 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.